ABOUT US ABOUT US
ABOUT US OUR TEAM CULTURE JOIN US
NEWS news
COMPANY NEWS MEDIA NEWS
CDMO CDMO service
One-Stop-Shop CDMO services Process Science Analytical Science Good Manufacturing Practice Supply Chain System Quality Management
COUSTOMERS
CONTACT
Developability Assessment Technical Platform for Drug Candidates
High expression stable cell lines construction
In house developed serum-free culture medium
Integrated Manufacturing Process
Product Lifecycle Quality Control
VR display in production workshop
Process Development, Tox, Clinical and Commercial Manufacturing
DS MFG workshop
water-making room
Bosch Commercial Vial-Filling Line
CDMO Capacity Continues to Expand MFG Facility (2,000L) obtained Manufacture License of Pharmaceutical Products issued by NMPA in 2021; additional 6,000L of MFG capacity to be commissioned by the end of 2022; Total MFG capacity 48,000L expected by Q3 2025.

1st MFG Facility in Beijing

1st MFG Facility in Beijing (2,000L) obtained Manufacture License of Pharmaceutical Products issued by NMPA in 2021; additional 6,000L of MFG capacity to be commissioned by the end of 2022; Total MFG capacity 44,000L expected by Q3 2024

3rd MFG Facility in Hangzhou (Under Construction)

Expected to be commissioned by Q3 2024
MFG, Lab & Office space: 38,000 m²
Phase I: 36,000L (total) stainless steel and single-use bioreactor lines
Commercial vial and PFS filling lines

ABOUT US NEWS CDMO COUSTOMERS CONTACT
LINK
TEL：010-57585100 HR Recruiting：HR@nyexpo.net Business：BD@nyexpo.net

COPYRIGHT © FOSTERBIO. All Rights Reserved .京ICP备2021037222号-3